中保協:110家險企機構合計擁有249項投資管理能力 94家險企暫未具備
中國保險行業協會對保險機構首次自評估結果進行通報顯示,截至2021年3月31日,共有110家保險公司具備不同類型的投資管理能力(包括信用風險管理、股票投資、股權投資、不動產投資和衍生品運用管理等五項能力)合計249項,其中40項能力為45號文件發布後新增。94家保險公司暫未具備任何投資管理能力。
據《券商中國》報道,數據顯示,六家保險集團公司中,中華保險能力最為全面,拿下除衍生品以外的四項能力;泰康保險、陽光保險和中國平安均拿下股權和不動產兩項能力;中國人保和中國太平則僅拿下信用風險一項能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.